LAPPE MARK (Chief Executive Officer) purchased 7.1% of their position (44K shares) of INHIBRX BIOSCIENCES, INC. on the open market
Open‑market purchase worth $671.1K — a moderate purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 9/10/2024ACC: 0002007919-24-000045
DirectorOfficer· Chief Executive Officer
Since May 2024
+44K
Net shares
Net buyer
$671.1K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
44K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+26K
Price / share
$15.29
Trade value
$397.54K
% of position
4.2%
9/6/2024
621.55K→647.55K
Common Stock
Indirect
Shares
+9.50K
Price / share
$15.21
Trade value
$144.50K
% of position
1.5%
9/9/2024
647.55K→657.05K
Common Stock
Indirect
Shares
+8.50K
Price / share
$15.19
Trade value
$129.12K
% of position
1.3%
9/10/2024
657.05K→665.55K
Total
Net shares
+44K
Net value
$671.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/6/2024 | P · Purchase | +26K | $15.29 | $397.54K | 4.2% | 621.55K | 647.55K |
| Common Stock Indirect | 9/9/2024 | P · Purchase | +9.50K | $15.21 | $144.50K | 1.5% | 647.55K | 657.05K |
| Common Stock Indirect | 9/10/2024 | P · Purchase | +8.50K | $15.19 | $129.12K | 1.3% | 657.05K | 665.55K |
| Total | +44K | $671.15K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned54.87K
Common Stock
IndirectShares owned165K
Total
219.87K indirect219.87K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 54.87K | Indirect |
| Common Stock | 165K | Indirect |
| Total | 219.87K | 219.87K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported